Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Friscia

Orthopaedic Surgery Rancho Mirage, CA Medical Doctor

NPI 1295750255 CMS profile 57967

39000 Bob Hope Dr, Harry & Diane Rinker Building, Rancho Mirage, CA 92270

Open in the dashboard

General payments

$151,932

408 records reported · program years 2019–2025

Research payments

$4,233

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$600,001

11 holdings reported · through program year 2025

Research they led as principal investigator

$47,460 paid to institutions, not to them · program years 2019–2024

Through program year 2025, David Friscia of Rancho Mirage, CA is reported in the CMS Open Payments database as having received $151,932 across 408 general payments and $4,233 in research payments paid to them. Separately, studies naming them as principal investigator received $47,460 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $600,001 across 11 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,628 87
2024 General $9,299 70
2023 General $43,814 62
2022 General $19,408 35
2022 Research $4,233 2
2021 General $45,208 93
2020 General $3,129 17
2019 General $10,447 44
2025 Ownership $140,000 2
2024 Ownership $140,000 2
2023 Ownership $90,000 2
2022 Ownership $90,000 2
2021 Ownership $140,000 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Friscia
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to David Friscia were reported at $20,628. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year David Friscia Orthopaedic Surgery median Middle half National median
2019 $10,447 $644 $140–$2,844 $163
2020 $3,129 $312 $75–$1,860 $114
2021 $45,208 $520 $117–$2,495 $132
2022 $19,408 $598 $128–$2,731 $149
2023 $43,814 $461 $128–$2,264 $160
2024 $9,299 $497 $134–$2,475 $164
2025 $20,628 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Treace Medical Concepts, Inc. $83,561 122 payments
  2. Stryker Corporation $26,677 109 payments
  3. Arthrex, Inc. $9,657 54 payments
  4. Paragon 28, Inc. $9,529 37 payments
  5. Empire Medical, Inc $5,864 6 payments
  6. Wright Medical Technology, Inc. $4,190 23 payments
  7. TriMed, Inc. $3,116 4 payments
  8. SportsTek Medical, Inc $1,736 4 payments
  9. MedShape, Inc. $1,659 5 payments
  10. Exactech, Inc. $1,578 4 payments
  11. Other $4,365 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $87,948 20 payments
  2. Travel and Lodging $34,196 119 payments
  3. Food and Beverage $19,160 260 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,000 4 payments
  5. Education $4,533 4 payments
  6. Gift $95 1 payment
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM Foot And Ankle $45,983 47 payments
  2. Lapiplasty System Y $21,749 28 payments
  3. INFINITY Trauma & Extremities $18,247 44 payments
  4. ORTHOLOC 2 LAPIFUSE $14,107 6 payments
  5. LAPIPLASTY SYSTEM 1 $13,958 20 payments
  6. AUGMENT INJECTABLE $10,852 5 payments
  7. PORTFOLIO $6,372 8 payments
  8. SONICANCHOR $3,886 9 payments
  9. INBONE $3,556 20 payments
  10. INFINITY Foot And Ankle $3,460 12 payments
  11. Other $18,714 158 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Stryker Corporation $4,233 2 payments

Billing to Medicare

Part B · data year 2024 · 133 billing codes

Paid by Medicare

$237,583

Medicare's payments for the services billed

Medicare patients

565

Average age 74

Services billed

2,163

319 women, 246 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Ischemic heart disease 28%
Depression 28%
Diabetes 23%
Chronic kidney disease 23%
Osteoporosis 20%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

410 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record